Give your mother or father something they'll cherish this Mother's Day or Father's Day and give the gift of hope to thousands of patients battling cancer.
At The Leukemia & Lymphoma Society's Photo Gift Store , you can purchase great items - mugs, blankets, jewelry, ties, watches, calendars and much more - and personalize them with your own photos. The proceeds from your purchase help in the search to find cures for cancer. All you have to do is browse the store, click on the photo gifts you like, upload your photos and make the purchase.
Orders should be placed by April 28 for regular mail, and by May 3 for expedited service, to ensure delivery by Mother's Day, Sunday, May 9th. Father's Day orders should be placed June 4 for regular mail, and by June 14 for expedited service, to ensure delivery by the holiday, Sunday June 20th, 2010.
So give mom or dad a little piece of yourself this Mother's Day and make a difference in the lives of others.
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...